Alexion to Acquire Wilson Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Alexion Pharmaceuticals (ALXN) PT Raised to $113 at Jefferies on Plan to Acqurie WTX101
April 11, 2018 11:37 AM EDTJefferies raised its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $113.00 (from $112.00) while maintaining a Hold rating.
Analyst Eun Yang said the clinical risk is low, but the commercial risk seems tougher.
... More


